ReleaseWire Connect

Transparency Market Research in one of its new research reports, says the global collagen market is largely held by a few top players that offer myriad product offerings for most applications of collagen. The small number of global players for niche application segments and a considerable increase in the incidence of chronic diseases such as diabetes and cancer will aid collagen companies to thrive in their specialty segment.

Takeda Pharmaceuticals Company, Ltd., with its approved drug Amitiza, holds a majority share in the global market for opioid induced constipation treatment. In 2014 the top three players - Takeda, Valeant Pharmaceuticals International, Ltd., and Boehringer Ingelheim – operated on a collective share of 91.8% of the global market.

Over the past few years, the market for aesthetic services has witnessed a surge in research activities. Vast developments in the area has increased the overall knowledge of the mankind about bioengineered products capable of treating naturally occurring superficial skin imperfections or scars resulting from wounds, acne, burns, and other issues.

According to the World Cancer Research Fund International, breast cancer is the most common cancer in women, with an estimated 1.7 million new cases diagnosed in 2012. The highest incidence of breast cancer was in North America and Oceania. The incidence of breast cancer in North America was estimated at 80 per 100,000 individuals in Canada and around 92 per 100,000 in the U.S.

Biobanks are kind of repositories which store the biological samples for research and educational purpose. The samples are collected form general public based on various factors such as ethnicity, age, gender, lifestyle and geography. Biobanks collect the samples in various forms such as tissues, saliva, blood, etc. A purified genomic database is maintained in these biobanks, this data is significant in research and study purpose for understanding the environmental impacts and mutations, and diseases and disorders derived from them. The samples are stored in groups of specific traits to ease their application in research purposes. The samples are collected from donors after their consensus and most of the biobanks follow the practice of donor's ownership and his consensus on use of his/her sample for any further research purpose by private entity or public organization. Biobanks play a vital role in research and development is healthcare industry.

The global in-vitro colorectal cancer screening tests market has been foreseen by Transparency Market Research (TMR) analysts to witness the lead secured by top three companies, viz. Sysmex Corporation, Quest Diagnostics, Inc., and Beckman Coulter, Inc. In the recent past, these companies had attracted a significant share for in-vitro colorectal cancer screening tests. According to a TMR report, new entrants could pose a substantially low threat in the market on account of its extremely consolidated nature. This has been anticipated to be in view of increasing regulatory pressure enforced by the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA). Besides this, enormous shares exhibited by leading companies via long-term contracts and mergers and acquisitions could restrict the entry of new players.

The global postpartum hemorrhage (PPH) treatment devices market currently features a highly fragmented competitive landscape, according to a research report published by Transparency Market Research. The leading players in the market – including Teleflex Inc., Utah Medical Products, and C.R. Bard – are currently investing strongly into marketing strategies that promote their newer products as alternatives to conventional methods of treating postpartum hemorrhage. While it is creating higher awareness among patients and the healthcare industry, it increases the overall cost of business, which eventually reflects on higher product pricing. This is creating a moderate volume of aversion to the more expensive products due to the presence of regional players that can offer the conventional products at cheaper rates. This trend is especially prevalent in emerging economies.

The global market for angioplasty balloons is likely to have a dense and highly dynamic competitive scenario of the years ahead, states Transparency Market Research (TMR) in a research report. The core players namely Abbott Laboratories, Cordis Corporation, and Boston Scientific held a share of 71.7% collectively in 2014 in the global angioplasty balloons market. TMR also states that the existing players might be threatened by the entry of new players in the market over the next couple of years, but the threat might stay moderate for some time now. This is mainly due to the expensive research and development involved in this field and the strict government policies that tend to differ from region to region. Moreover, the growth of the market is likely to have a slow place to make enough scope for the entry of new players. The race to stay ahead has given rise a plethora of innovations taking and product launches.

An up-to-date study by Transparency Market Research (TMR) reports that the global forensic technologies market is intensely competitive, although a few players do hold a position of strength. Some of the key companies identified by the TMR report in the global forensic technologies market are: Thermo Fisher Scientific, Agilent Technologies, LGC Limited, SPEX Forensics, Forensics Consulting Solutions, LLC, NMS Labs, GE Healthcare Life Sciences, Eurofins Medigenomix GmbH, Neogen Corporation, Forensic Pathway, SCIEX (Danaher Corporation).

The global coagulation testing market has multiple leading market players, resulting in market consolidation and a high degree of competitive rivalry. Some of the key players in the global coagulation testing market are Alere Inc., F. Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthineers, SYSMEX CORPORATION, Universal Biosensors, Inc., HemoSonics, LLC, and Helena Laboratories, Inc.